Search

Your search keyword '"van Leeuwen F.E."' showing total 43 results

Search Constraints

Start Over You searched for: Author "van Leeuwen F.E." Remove constraint Author: "van Leeuwen F.E." Database OAIster Remove constraint Database: OAIster
43 results on '"van Leeuwen F.E."'

Search Results

1. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

2. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

3. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (Nature Communications, (2021), 12, 1, (1078), 10.1038/s41467-020-20496-3).

4. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

5. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Results from the BRCA1 and BRCA2 cohort consortium.

6. Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.

7. Prediction and clinical utility of a contralateral breast cancer risk model.

8. Erratum: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers (Breast Cancer Res (2020) 22 (8) DOI: 10.1186/s13058-020-1247-4).

9. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers.

10. Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: Methodological aspects of the Dutch late effects after childhood cancer (LATER) cardiology study

11. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Results from the BRCA1 and BRCA2 cohort consortium.

12. Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts.

13. Prediction and clinical utility of a contralateral breast cancer risk model.

14. Erratum: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers (Breast Cancer Res (2020) 22 (8) DOI: 10.1186/s13058-020-1247-4).

15. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: An international prospective cohort of BRCA1 and BRCA2 mutation carriers.

16. Risk of cancer in children and young adults conceived by assisted reproductive technology

17. Oral contraceptive use and breast cancer risk: Retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study.

18. Oral contraceptive use and breast cancer risk: Retrospective and prospective analyses from a BRCA1 and BRCA2 mutation carrier cohort study.

22. Bijdrage van leefstijlfactoren aan kanker: SECUNDAIRE ANALYSE VAN NEDERLANDSE GEGEVENS VOOR 2010 MET EEN VOORSPELLING VOOR 2020

23. The proportion of postmenopausal breast cancer cases in the Netherlands attributable to lifestyle-related risk factors

24. Bijdrage van leefstijlfactoren aan kanker : Sec undaire ana lyse van Neder landse gegevens voor 2010 met een voors pelling voor 2020

25. Factors associated with dizygotic twinning after IVF treatment with double embryo transfer

26. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours

27. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

28. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

29. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

30. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

31. Factors associated with dizygotic twinning after IVF treatment with double embryo transfer

32. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours

33. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

34. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

35. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

36. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

37. Risk and prognostic significance of metachronous contralateral testicular germ cell tumours

38. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

39. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

40. Factors associated with dizygotic twinning after IVF treatment with double embryo transfer

41. Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls

42. Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls

43. Lycopene supplementation elevates circulating insulin-like growth factor-binding protein-1 and-2 concentrations in persons at greater risk of colorectal cancer

Catalog

Books, media, physical & digital resources